尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the complete record of transactions filed by Sofia Michael J., 管理人员. Insider active across 1 company, notably Arbutus Biopharma Corp. In total, 3 disclosures have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €898k. History available since 1 December 2021. The latest transaction was disclosed on 1 February 2024 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Michael J. Sofia is the Chief Scientific Officer at Arbutus Biopharma Corp. In this role, he is responsible for leading the company's research and development efforts, which focus on antiviral treatments. Sofia plays a key role in scientific innovation and the development of new therapies.